Notices. Notice
340 words·~2 min read·
/register/2016/12/19/2016-30351A research copy — for the controlling text, always check the official state or federal source. Not legal advice.
BILLING CODE 4164-01-P DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration [Docket Nos. FDA-2012-N-0873; FDA-2008-D-0031; FDA-2013-N-0242; FDA-2013-N-0125; FDA-2013-N-0093; FDA-2016-N-1593; FDA-2015-N-2406; FDA-2013-N-0450; FDA-2011-N-0830] Agency Information Collection Activities; Announcement of Office of Management and Budget Approvals AGENCY: Food and Drug Administration, HHS. ACTION: Notice. SUMMARY: The Food and Drug Administration
(FDA)is publishing a list of information collections that have been approved by the Office of Management and Budget
(OMB)under the Paperwork Reduction Act of 1995. FOR FURTHER INFORMATION CONTACT: FDA PRA Staff, Office of Operations, Food and Drug Administration, Three White Flint North, 11601 Landsdown St., North Bethesda, MD 20852, *PRAStaff@fda.hhs.gov.* SUPPLEMENTARY INFORMATION: The following is a list of FDA information collections recently approved by OMB under section 3507 of the Paperwork Reduction Act of 1995 (44 U.S.C. 3507). The OMB control number and expiration date of OMB approval for each information collection are shown in table 1. Copies of the supporting statements for the information collections are available on the Internet at *http://www.reginfo.gov/public/do/PRAMain.* An Agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB control number. Table 1—List of Information Collections Approved By OMB Title of collection OMB control No. Date approval expires Bar Code Label Requirements for Human Drug Products and Biological Products 0910-0537 9/30/2019 Clinical Laboratory Improvement Amendments Waiver Applications 0910-0598 9/30/2019 Current Good Manufacturing Practices for Positron Emission Tomography Drugs 0910-0667 9/30/2019 Medical Devices: Use of Certain Symbols in Labeling—Glossary to Support the Use of Symbols in Labeling 0910-0740 9/30/2019 Evaluation of the Program for Enhanced Review Transparency and Communication for New Molecular Entity New Drug Applications and Original Biologics License Applications in Prescription Drug User Fee Act 0910-0746 9/30/2019 Medical Device Accessories 0910-0823 9/30/2019 Market Claims in Direct-to-Consumer Prescription Drug Print Ads 0910-0824 9/30/2019 Abbreviated New Animal Drug Applications 0910-0669 10/31/2019 Abbreviated New Drug Applications and 505(b)(2) Applications 0910-0786 11/30/2019 Dated: December 13, 2016. Leslie Kux, Associate Commissioner for Policy. [FR Doc. 2016-30351 Filed 12-16-16; 8:45 am]
Connectionstraces to 1
Traces to 1 document